306 related articles for article (PubMed ID: 34708326)
1. Recent advances in lentiviral vectors for gene therapy.
Wang X; Ma C; Rodríguez Labrada R; Qin Z; Xu T; He Z; Wei Y
Sci China Life Sci; 2021 Nov; 64(11):1842-1857. PubMed ID: 34708326
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies.
Daniel-Moreno A; Lamsfus-Calle A; Wilber A; Chambers CB; Johnston I; Antony JS; Epting T; Handgretinger R; Mezger M
Blood Cells Mol Dis; 2020 Sep; 84():102456. PubMed ID: 32498026
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of lentiviral vectors.
Milone MC; O'Doherty U
Leukemia; 2018 Jul; 32(7):1529-1541. PubMed ID: 29654266
[TBL] [Abstract][Full Text] [Related]
4. Taking the good out of the bad: lentiviral-based gene therapy of the hemoglobinopathies.
Stathopulos PB
Biotechnol Adv; 2003 Sep; 21(6):513-26. PubMed ID: 14499152
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in lentiviral vector development and applications.
Mátrai J; Chuah MK; VandenDriessche T
Mol Ther; 2010 Mar; 18(3):477-90. PubMed ID: 20087315
[TBL] [Abstract][Full Text] [Related]
6. Droplet digital polymerase chain reaction-based quantitation of therapeutic lentiviral vector copies in transduced hematopoietic stem cells.
Phuphanitcharoenkun S; Bhukhai K; Phanthong P; Prasongtanakij S; Linn AK; Sutjarit N; Anurathapan U; Leboulch P; Payen E; Hongeng S; Borwornpinyo S
Cytotherapy; 2024 Jun; 26(6):586-591. PubMed ID: 38551525
[TBL] [Abstract][Full Text] [Related]
7. Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy.
Gouvarchin Ghaleh HE; Bolandian M; Dorostkar R; Jafari A; Pour MF
Biomed Pharmacother; 2020 Aug; 128():110276. PubMed ID: 32502836
[TBL] [Abstract][Full Text] [Related]
8. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
[TBL] [Abstract][Full Text] [Related]
9. Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications.
Kumar P; Woon-Khiong C
Curr Gene Ther; 2011 Apr; 11(2):144-53. PubMed ID: 21291355
[TBL] [Abstract][Full Text] [Related]
10. Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs.
Girard-Gagnepain A; Amirache F; Costa C; Lévy C; Frecha C; Fusil F; Nègre D; Lavillette D; Cosset FL; Verhoeyen E
Blood; 2014 Aug; 124(8):1221-31. PubMed ID: 24951430
[TBL] [Abstract][Full Text] [Related]
11. Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancers.
Ingrao D; Majdoul S; Seye AK; Galy A; Fenard D
Hum Gene Ther Methods; 2014 Feb; 25(1):48-56. PubMed ID: 24152219
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to lentiviral vectors.
Follenzi A; Santambrogio L; Annoni A
Curr Gene Ther; 2007 Oct; 7(5):306-15. PubMed ID: 17979677
[TBL] [Abstract][Full Text] [Related]
13. The new self-inactivating lentiviral vector for thalassemia gene therapy combining two HPFH activating elements corrects human thalassemic hematopoietic stem cells.
Papanikolaou E; Georgomanoli M; Stamateris E; Panetsos F; Karagiorga M; Tsaftaridis P; Graphakos S; Anagnou NP
Hum Gene Ther; 2012 Jan; 23(1):15-31. PubMed ID: 21875313
[TBL] [Abstract][Full Text] [Related]
14. Pseudotyped Lentiviral Vectors: One Vector, Many Guises.
Joglekar AV; Sandoval S
Hum Gene Ther Methods; 2017 Dec; 28(6):291-301. PubMed ID: 28870117
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.
Gutierrez-Guerrero A; Cosset FL; Verhoeyen E
Viruses; 2020 Sep; 12(9):. PubMed ID: 32933033
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E
Heffner GC; Bonner M; Christiansen L; Pierciey FJ; Campbell D; Smurnyy Y; Zhang W; Hamel A; Shaw S; Lewis G; Goss KA; Garijo O; Torbett BE; Horton H; Finer MH; Gregory PD; Veres G
Mol Ther; 2018 Jan; 26(1):320-328. PubMed ID: 29102562
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
Persons DA
Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
[TBL] [Abstract][Full Text] [Related]
18. Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis.
Ornaghi F; Sala D; Tedeschi F; Maffia MC; Bazzucchi M; Morena F; Valsecchi M; Aureli M; Martino S; Gritti A
Neurobiol Dis; 2020 Feb; 134():104667. PubMed ID: 31682993
[TBL] [Abstract][Full Text] [Related]
19. β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion Production.
Han J; Tam K; Ma F; Tam C; Aleshe B; Wang X; Quintos JP; Morselli M; Pellegrini M; Hollis RP; Kohn DB
Stem Cell Reports; 2021 Jan; 16(1):198-211. PubMed ID: 33186538
[TBL] [Abstract][Full Text] [Related]
20. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
